Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Lexicon Pharmaceuticals is a US-based biopharmaceutical company dedicated to researching and developing innovative medicines for chronic diseases. The company is advancing novel therapeutic approaches, particularly for diabetes, kidney diseases, and cardiovascular disorders, aiming to provide improved treatment options for patients globally.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Lexicon Pharmaceuticals is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Lexicon Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.07 USD.
Across its last 3 earnings reports, Lexicon Pharmaceuticals stock moved by ±3.1% on average the following day. The largest reaction was +5% on 05/07/2026; 3 of 3 reactions were positive.
Lexicon Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.